A Genome-Scale CRISPR Screen Reveals PRMT1 as a Critical Regulator of Androgen Receptor Signaling in Prostate Cancer

Via genome-scale CRISPR-Cas9 screening, scientists identified protein arginine methyltransferase 1 (PRMT1) as a critical mediator of androgen receptor expression and signaling.